University of Wisconsin–Madison

Tag: ARVO 2022

Influence of Race on Training Data Quality for Artificial Intelligence (AI) Algorithms (2022)

Amitha Domalpally, Rick Voland, Robert Slater, Ellie Corkery, Pamela Vargo, Rebecca Kuhtz, James Reimers, Roomasa Channa, Barbara Blodi Abstract Purpose: Diabetic retinopathy (DR) severity level is evaluated from stereoscopic 7-field color photographs by masked graders at the Wisconsin Reading Center and used as a reference standard for training and validation of AI algorithms. Training data …

Implementation of a Large-Scale Retinal Image Curation Workflow Using Deep Learning Framework (2022)

Rohit Balaji, Jen Heathcote, Robert Slater, Nancy Barrett, Rick Voland, Vesna Tomic, Jared McDonald, Barbara A. Blodi, Amitha Domalpally Abstract Purpose: The development of artificial intelligence (AI) algorithms for analyzing retinal pathologies requires training based on well-organized, labeled images. The goals of this project are to develop an AI model to curate 7-field retinal photographs …

Artificial Intelligence (AI) enabled pre-screening for Diabetic Retinopathy (DR) clinical trials (2022)

Nancy Barrett, Robert Slater, Roomasa Channa, Barbara Blodi, Amitha Domalpally Abstract Purpose: Preventive therapies to reduce progression of non-proliferative DR (NPDR) to proliferative DR are underway. Clinical trial enrollment criteria typically include a baseline DR severity scale (DRSS) of moderately severe (level 47) or severe NPDR (level 53) determined from stereoscopic 7-field retinal color photographs …

Multimodal Imaging Evaluation of Age-Related Macular Degeneration (AMD) in the AMD Ryan Initiative Study (ARIS) (2022)

Andrew Dieu, Cynthia Hurtenbach, Jeong W. Pak, Tiarnan D. Keenan, Frederick L. Ferris, Charles P. Wilkinson, Christine Orndahl, Traci E. Clemons, Emily Y. Chew, Amitha Domalpally Abstract Purpose: ARIS is a 5-year, multicenter, international, prospective, observational cohort study of participants with early AMD or reticular pseudodrusen (RPD) to identify novel biomarkers of disease progression. The …